Dr. Rodman S. Rogers, MD

Dr. Rogers practices at Golden Gate Urology Inc in San Francisco, California.

Dr. Rogers' NPI, 1073617023, was assigned on September 12, 2006. Dr. Rogers graduated from OU College of Medicine in 1995. Dr. Rogers holds California license A62450.

Dr. Rogers' primary practice is Golden Gate Urology Inc, at 2186 Geary Blvd, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 543-2830.

Dr. Rogers' primary practice is Golden Gate Urology Inc in San Francisco, California. Dr. Rogers is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Rogers to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rogers practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Rogers' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Rogers is board certified in urology by the American Board of Urology. Dr. Rogers is licensed in California.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate cancer, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Rogers treats.

CMS data shows 2,517 Medicare services from Dr. Rogers across 17 procedure codes in 2024, for 778 Medicare patients. Medicare paid $271,794 for them.

CMS counts 778 Medicare patients who saw Dr. Rogers in 2024. The largest group is 75 to 84, with 346 patients. 73% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rogers' median patient age at 75, with 9% women.

In 2024, Dr. Rogers wrote 4,377 Medicare Part D claims for 865 patients. 88% of them were for generic drugs. CMS names the drug for 4,285 of them, across 25 drugs with 11 or more claims each, at $561,907 in total drug cost. In 2023, CMS named 4,151 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rogers for performance year 2024, reported as part of a group. Dr. Rogers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rogers as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Rogers. The most frequent topics are Microscopy, Electron, Rats, Sprague-Dawley and Penis. Dr. Rogers has published most often in J Urol. Dr. Rogers' most frequent co-authors are Shahram Shawn Gholami, MD, Peter R. Carroll, MD and Johnny A. Chang, MD.

CMS Open Payments shows 577 general payments to Dr. Rogers from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Sumitomo Pharma America, Inc. paid the most, $2,470.

Dmand AI lists 1 award for Dr. Rogers.

Dr. Rogers graduated from OU College of Medicine in 1995.

Dr. Rogers is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.